Europe urges convention against counterfeit goods
This article was originally published in Clinica
On April 20, parliamentarians from the 46 member states of the Council of Europe unanimously backed a call for a European convention against counterfeit medicines which is expected to also cover medical devices and other healthcare products. The vote at the spring session of the CoE Parliamentary Assembly was designed to lend political support to ongoing efforts by CoE officials as they seek to broker pan-European consensus on the project.
You may also be interested in...
The UK has approved the mRNA-based vaccine just nine days after receiving the final Phase III results from Pfizer.
As the MHRA prepares to grant approval to the Oxford/AstraZeneca vaccine, Wockhardt is set to supply 100 million doses for the UK government’s own use and its WHO commitments. The company is also in talks with global vaccine developers to manufacture their COVID-19 vaccines for emerging economies
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.